Opioid — Product liability contingency, number of claimants
Products & Services · Product liability contingency, number of claimantsJohnson & Johnson Opioid — Product liability contingency, number of claimants remained flat by 0.0% to $3.50K in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $3.50K to $3.50K. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2019
Last reportedQ3 2025
How to read this metric
An increase suggests expanding legal exposure and potential future financial liability, while a decrease may indicate progress in settlement negotiations or case dismissals.
Detailed definition
Represents the total count of individual or entity plaintiffs asserting legal claims related to product liability for op...
Peer comparison
Comparable to mass tort litigation metrics in the pharmaceutical or chemical industries.
Metric ID:
jnj_segment_opioid_product_liability_contingency_number_of_claimantsHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.20K | $3.20K | $3.30K | $3.40K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K | $3.50K |
| QoQ Change | — | +0.0% | +3.1% | +3.0% | +2.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +9.4% | +9.4% | +6.1% | +0.0% | +0.0% | +0.0% | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$3.20K – $3.50K
CAGR+2.3%
Avg YoY Growth+2.1%
Median YoY Growth+0.0%
Current Streak16+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's opioid — product liability contingency, number of claimants?
- Johnson & Johnson (JNJ) reported opioid — product liability contingency, number of claimants of $3.50K in Q3 2025.
- How has Johnson & Johnson's opioid — product liability contingency, number of claimants changed year-over-year?
- Johnson & Johnson's opioid — product liability contingency, number of claimants decreased by 0.0% year-over-year, from $3.50K to $3.50K.
- What does opioid — product liability contingency, number of claimants mean?
- The total number of people or entities suing the company over opioid-related product issues.